Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

6.09
Delayed Data
As of May 27
 +0.01 / +0.16%
Today’s Change
4.38
Today|||52-Week Range
7.16
+6.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-14.9M4.5M-336.0K515.0K
 
 
 
 
 
Depreciation4.5M6.7M8.4M6.5M
 
 
 
 
 
Total Other Cash Flow998.4K9.5M2.0M510.0K
 
 
 
 
 
Funds From Operations-9.4M18.5M9.9M7.0M
 
 
 
 
 
Funds From/For Other Operating Expenses6.9M12.9M18.5M2.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-16.3M5.6M-8.6M4.3M
 
 
 
 
 
 
InvestingCapital Expenditures-16.2M-5.2M-11.0M-5.3M
 
 
 
 
 
Fixed Asset Disposal5.4K0.000.00882.0K
 
 
 
Other Investing - Uses0.000.000.00-98.0K
 
 
Net Cash Flow Investing-16.2M-5.2M-11.0M-4.5M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings16.8M16.8M17.8M21.3M
 
 
 
 
 
Long Term Debt Reduction-4.8M-4.1M-16.6M-46.8M
 
 
 
 
 
Net Proceeds Stock Sale515.7K848.0K512.0K750.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing5.6M860.0K3.6M544.0K
 
 
 
 
 
Other Uses - Financing802.2K0.000.000.00
 
 
Net Cash Flow - Financing17.3M14.4M5.3M-24.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash2.0M1.2M-1.4M-1.5M
 
 
 
 
 
 
Net Change In Cash-15.1M14.8M-14.3M-24.4M